Evaluation of the effect of the antiepiletic levetiracetum on seizure control and expression of MGMT in patients with gliomas (Phase II clinical trial)
Not Applicable
Recruiting
- Conditions
- glioma
- Registration Number
- JPRN-UMIN000017531
- Lead Sponsor
- Department of Neurosurgery, Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. History of allergy to the ingredients of levetiracetum or pyrrolidones 2. History of status epilepticus or intractable epilepsy 3. Serious psychotic disorder 4. Pregnant or breast feeding women 5. Severe heart disease, or liver dysfunction, or renal dysfunction
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method